滬醫保12條措施支持“互聯網+”醫療服務試行納入醫保支付 利好在線醫療龍頭平安好醫生(1833.HK)
格隆匯2月24日丨昨天下午舉行的上海市疫情防控工作領導小組新聞發佈會透露,為全面服務疫情防控和統籌做好日常醫療保障,本市醫保部門在前期工作基礎上,推出“醫保12條”措施:包括支持“互聯網+”醫療服務試行納入醫保支付、合理增加醫保總額預算管理指標、鼓勵醫療機構開展新技術新項目、穩妥實施本市新版醫保藥品目錄、激勵家庭醫生做好居民簽約服務等。平安好醫生是中國最大的互聯網醫療健康服務平台。據中國平安年報,截至2019年12月31日,平安好醫生累計註冊用户量超3.15億,12月當月活躍用户數達6690萬。疫情期間的數據顯示,平安好醫生平台累計訪問人次達11.1億,APP新用户註冊量增長10倍,APP新增用户日均問診量是平時的9倍,相關視頻累計播放量超9800萬。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.